Phlox Therapeutics
Naarden
About Phlox Therapeutics
Phlox Therapeutics specializes in the development of gene therapy to alleviate and cure cardiomyopathies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Grant (Nov 2024)
- Website: phloxtherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/phlox-therapeutics-134779 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.